SCHEMBL24090052

SCHEMBL24090052

c1ccc2cc(-c3ccc(-c4c5ccccc5c(-c5ccc(-c6cccc7oc8ccccc8c67)cc5)c5ccccc45)cc3)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ CASP3 P42574 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ HSD17B1 P14061 1/20 0.37
▸ HSD17B2 P37059 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ PLA2G2A P14555 2/20 0.37
▸ PLA2G4A P47712 2/20 0.37
▸ GPR84 Q9NQS5 1/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ GSTP1 P09211 1/20 0.36
▸ PRKDC P78527 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17320839 0.97 PLA2G2A (0.41) ESR1ESR2CASP3SENP7SENP6
SCHEMBL17320741 0.96 L3MBTL1 (0.38) CASP3SENP7SENP6HCRTR1HSD17B1
SCHEMBL17320738 0.95 HSD17B1 (0.39) ESR1ESR2CASP3SENP7SENP6
SCHEMBL20650026 0.94 ESR1 (0.39) ESR1ESR2CASP3SENP7SENP6
SCHEMBL26950090 0.92 ESR1 (0.37) ESR1ESR2CASP3SENP7SENP6
SCHEMBL22063082 0.92 HDAC4 (0.38) CASP3SENP7SENP6HCRTR1HSD17B1
SCHEMBL26949832 0.92 ESR1 (0.37) ESR1ESR2CASP3SENP7SENP6
SCHEMBL22062620 0.92 HDAC4 (0.42) CASP3SENP7SENP6HCRTR1HSD17B1
SCHEMBL27341266 0.90 L3MBTL1 (0.37) HSD17B1HSD17B2TDP1L3MBTL1HDAC4
SCHEMBL27301737 0.90 HDAC4 (0.39) HSD17B1HSD17B2TDP1L3MBTL1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11665962-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-05-30 — — US disclosed
US-11665962-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-05-30 — — US disclosed
US-20210384445-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210384445-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE ESR1, EML4, L1CAM ESR1 1/4885ESR2 11/4885CASP3 3761/4885
US-11665962-B2 Organic electroluminescence element and electronic device ESR1, EML4, L1CAM ESR1 1/4885ESR2 11/4885CASP3 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback